Singularity HubHow to Feed 9.7 Billion People? CRISPR Gene Editing For CropsSingularity HubNow the emergence of the gene-editing tool CRISPR/Cas9 is making it possible to precisely edit the native DNA of organisms with the potential to dramatically inc… Continue reading
Singularity HubHow to Feed 9.7 Billion People? CRISPR Gene Editing For CropsSingularity HubNow the emergence of the gene-editing tool CRISPR/Cas9 is making it possible to precisely edit the native DNA of organisms with the potential to dramatically inc… Continue reading
The Boston Globe |
Crispr Therapeutics gets European gene-editing patent
The Boston Globe Crispr Therapeutics Inc., a Swiss-based biotech with its main research lab in Cambridge, said Tuesday that it has won a broad patent in Europe for gene-editing technology licensed from the University of California in Berkeley and the University of Vienna. CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene EditingP&T Community European Patent Office to Grant Broad Claims on Patent Covering …Business Wire (press release) |
BioPharma Dive |
In twisting patent fight, CRISPR Therapeutics scores win in Europe …
BioPharma Dive … Harvard over similar claims in the U.S.; The EPO’s decision is welcome news for CRISPR Therapeutics and ERS Genomics, two biotechs which license the hot … Chardan Capital Markets Starts CRISPR Therapeutics (CRSP) at BuyStreetInsider.com Latest Stocks: The Analysts Set $27.00 Target Price for Crispr Therapeutics AG (CRSP)Petro Global News 24 Crispr Therapeutics AG (CRSP) Now Covered by Analysts at Chardan CapitalSports Perspectives Seeking Alpha –BBNS –Breaking Finance News all 26 news articles » |
USC News |
USC scientist fishes for stem cell-based arthritis treatments
USC News Scientist Joanna Smeeton explores stem cell-based approaches to studying — and eventually treating — the common cause of cold aversion, disability and pain. “We only have treatments for the larger joints where you can provide total replacements, but … |
Science Daily |
Interferon-beta producing stem cell-derived immune cell therapy on liver cancer
Science Daily Hoping to improve primary liver cancer including HCC and metastatic liver cancer therapies, researchers from Japan began studying induced pluripotent stem (iPS) cell-derived immune cells that produced the protein interferon-? (IFN-β). IFN-β exhibits … |